Genetic variation in SP-A2 leads to differential binding to Mycoplasma pneumoniae membranes and regulation of host responses

Journal of Immunology

Volumn 194, Issue 12, 2015, Pages 6123-6132

  Ledford, Julie G ^a,b   Voelker, Dennis R ^c   Addison, Kenneth J ^a,b   Wang, Ying ^a,b   Nikam, Vinayak S ^a   Degan, Simone ^a   Kandasamy, Pitachaimani ^c   Tanyaratsrisakul, Sasipa ^c   Fischer, Bernard M ^a   Kraft, Monica ^a,b   Hollingswort, John W ^a,d  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MUCIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN A2; UNCLASSIFIED DRUG; MUCIN 5AC; PROTEIN BINDING; SFTPA2 PROTEIN, HUMAN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL MEMBRANE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HSP A2 223K GENE; IMMUNOREGULATION; MOUSE; MYCOPLASMA PNEUMONIAE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; SP A2 GENE; TRACHEA MUCOSA; TRANSGENIC MOUSE; ANIMAL; CELL MEMBRANE; CHEMOTAXIS; GENE ORDER; GENE TARGETING; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; MALE; METABOLISM; MICROBIOLOGY; MUCUS; MYCOPLASMA PNEUMONIA; NEUTROPHIL; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; CELL MEMBRANE; CHEMOTAXIS; FEMALE; GENE EXPRESSION; GENE ORDER; GENE TARGETING; GENETIC VARIATION; GENETIC VECTORS; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUCIN 5AC; MUCUS; MYCOPLASMA PNEUMONIAE; NEUTROPHILS; PHOSPHORYLATION; PNEUMONIA, MYCOPLASMA; PROTEIN BINDING; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84931393744     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500104     Document Type: Article

References (41)

1. LeVine, A. M., J. Gwozdz, J. Stark, M. Bruno, J. Whitsett, and T. Korfhagen. 1999. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J. Clin. Invest. 103: 1015-1021.
2. LeVine, A. M., K. E. Kurak, J. R. Wright, W. T. Watford, M. D. Bruno, G. F. Ross, J. A. Whitsett, and T. R. Korfhagen. 1999. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am. J. Respir. Cell Mol. Biol. 20: 279-286.
3. Sano, H., and Y. Kuroki. 2005. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol. Immunol. 42: 279-287.
4. White, R. T., D. Damm, J. Miller, K. Spratt, J. Schilling, S. Hawgood, B. Benson, and B. Cordell. 1985. Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature 317: 361-363.
5. Floros, J., R. Steinbrink, K. Jacobs, D. Phelps, R. Kriz, M. Recny, L. Sultzman, S. Jones, H. W. Taeusch, H. A. Frank, et al. 1986. Isolation and characterization of cDNA clones for the 35-kDa pulmonary surfactant-associated protein. J. Biol. Chem. 261: 9029-9033.
6. Katyal, S. L., G. Singh, and J. Locker. 1992. Characterization of a second human pulmonary surfactant-associated protein SP-A gene. Am. J. Respir. Cell Mol. Biol. 6: 446-452.
7. Pettigrew, M. M., J. F. Gent, Y. Zhu, E. W. Triche, K. D. Belanger, T. R. Holford, M. B. Bracken, and B. P. Leaderer. 2007. Respiratory symptoms among infants at risk for asthma: association with surfactant protein A haplotypes. BMC Med. Genet. 8: 15.
8. Floros, J., H. M. Lin, A. García, M. A. Salazar, X. Guo, S. DiAngelo, M. Montaño, J. Luo, A. Pardo, and M. Selman. 2000. Surfactant protein genetic marker alleles identify a subgroup of tuberculosis in a Mexican population. J. Infect. Dis. 182: 1473-1478.
9. Floros, J., R. Fan, A. Matthews, S. DiAngelo, J. Luo, H. Nielsen, M. Dunn, I. H. Gewolb, J. Koppe, L. van Sonderen, et al. 2001. Family-based transmission disequilibrium test (TDT) and case-control association studies reveal surfactant protein A (SP-A) susceptibility alleles for respiratory distress syndrome (RDS) and possible race differences. Clin. Genet. 60: 178-187.
10. Floros, J., R. Fan, S. Diangelo, X. Guo, J. Wert, and J. Luo. 2001. Surfactant protein (SP) B associations and interactions with SP-A in white and black subjects with respiratory distress syndrome. Pediatr. Int. 43: 567-576.
11. El Saleeby, C. M., R. Li, G. W. Somes, M. K. Dahmer, M. W. Quasney, and J. P. DeVincenzo. 2010. Surfactant protein A2 polymorphisms and disease severity in a respiratory syncytial virus-infected population. J. Pediatr. 156: 409-414.
12. Guo, X., H. M. Lin, Z. Lin, M. Montaño, R. Sansores, G. Wang, S. DiAngelo, A. Pardo, M. Selman, and J. Floros. 2000. Polymorphisms of surfactant protein gene A, B, D, and of SP-B-linked microsatellite markers in COPD of a Mexican population. Chest 117(5Suppl. 1): 249S-250S.
13. Huang, W., G. Wang, D. S. Phelps, H. Al-Mondhiry, and J. Floros. 2004. Human SP-A genetic variants and bleomycin-induced cytokine production by THP-1 cells: effect of ozone-induced SP-A oxidation. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L546-L553.
14. Wang, Y., D. R. Voelker, N. L. Lugogo, G. Wang, J. Floros, J. L. Ingram, H. W. Chu, T. D. Church, P. Kandasamy, D. Fertel, et al. 2011. Surfactant protein A is defective in abrogating inflammation in asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 301: L598-L606.
15. Waites, K. B., and D. F. Talkington. 2004. Mycoplasma pneumoniae and its role as a human pathogen. Clin. Microbiol. Rev. 17: 697-728, table of contents.
16. Kraft, M., G. H. Cassell, J. E. Henson, H. Watson, J. Williamson, B. P. Marmion, C. A. Gaydos, and R. J. Martin. 1998. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am. J. Respir. Crit. Care Med. 158: 998-1001.
17. Kraft, M., G. H. Cassell, J. Pak, and R. J. Martin. 2002. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 121: 1782-1788.
18. Kraft, M., and Q. Hamid. 2006. Mycoplasma in severe asthma. J. Allergy Clin. Immunol. 117: 1197-1198.
19. Chmura, K., X. Bai, M. Nakamura, P. Kandasamy, M. McGibney, K. Kuronuma, H. Mitsuzawa, D. R. Voelker, and E. D. Chan. 2008. Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L220-L230.
20. Rawadi, G., and S. Roman-Roman. 1996. Mycoplasma membrane lipoproteins induced proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect. Immun. 64: 637-643.
21. Piboonpocanun, S., H. Chiba, H. Mitsuzawa, W. Martin, R. C. Murphy, R. J. Harbeck, and D. R. Voelker. 2005. Surfactant protein A binds Mycoplasma pneumoniae with high affinity and attenuates its growth by recognition of disaturated phosphatidylglycerols. J. Biol. Chem. 280: 9-17.
22. Kannan, T. R., D. Provenzano, J. R. Wright, and J. B. Baseman. 2005. Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect. Immun. 73: 2828-2834.
23. Ledford, J. G., B. Lo, M. M. Kislan, J. M. Thomas, K. Evans, D. W. Cain, M. Kraft, K. L. Williams, and J. R. Wright. 2010. Surfactant protein-A inhibits mycoplasma-induced dendritic cell maturation through regulation of HMGB-1 cytokine activity. J. Immunol. 185: 3884-3894.
24. Herrera-Ramos, E., M. López-Rodríguez, J. J. Ruíz-Hernández, J. P. Horcajada, L. Borderías, E. Lerma, J. Blanquer, M. C. Pérez-González, M. I. García-Laorden, Y. Florido, et al. 2014. Surfactant protein A genetic variants associate with severe respiratory insufficiency in pandemic influenza A virus infection. Crit. Care 18: R127.
25. Korfhagen, T. R., M. D. Bruno, G. F. Ross, K. M. Huelsman, M. Ikegami, A. H. Jobe, S. E. Wert, B. R. Stripp, R. E. Morris, S. W. Glasser, et al. 1996. Altered surfactant function and structure in SP-A gene targeted mice. Proc. Natl. Acad. Sci. USA 93: 9594-9599.
26. Chiba, H., S. Pattanajitvilai, A. J. Evans, R. J. Harbeck, and D. R. Voelker. 2002. Human surfactant protein D (SP-D) binds Mycoplasma pneumoniae by high affinity interactions with lipids. J. Biol. Chem. 277: 20379-20385.
27. Kuroki, Y., R. J. Mason, and D. R. Voelker. 1988. Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J. Biol. Chem. 263: 3388-3394.
28. Lankford, S. M., M. Macchione, A. L. Crews, S. A. McKane, N. J. Akley, and L. D. Martin. 2005. Modeling the airway epithelium in allergic asthma: interleukin-13- induced effects in differentiated murine tracheal epithelial cells. In Vitro Cell. Dev. Biol. Anim. 41: 217-224.
29. Ledford, J. G., S. Mukherjee, M. M. Kislan, J. L. Nugent, J. W. Hollingsworth, and J. R. Wright. 2012. Surfactant protein-A suppresses eosinophil-mediated killing of Mycoplasma pneumoniae in allergic lungs. PLoS One 7: e32436. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0032436.
30. Khubchandani, K. R., and J. M. Snyder. 2001. Surfactant protein A (SP-A): the alveolus and beyond. FASEB J. 15: 59-69.
31. Burgel, P. R., and J. A. Nadel. 2004. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 59: 992-996.
32. Takeyama, K., K. Dabbagh, H. M. Lee, C. Agustí, J. A. Lausier, I. F. Ueki, K. M. Grattan, and J. A. Nadel. 1999. Epidermal growth factor system regulates mucin production in airways. Proc. Natl. Acad. Sci. USA 96: 3081-3086.
33. Nakanaga, T., J. A. Nadel, I. F. Ueki, J. L. Koff, and M. X. Shao. 2007. Regulation of interleukin-8 via an airway epithelial signaling cascade. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L1289-L1296.
34. Kannan, T. R., and J. B. Baseman. 2006. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc. Natl. Acad. Sci. USA 103: 6724-6729.
35. Hardy, R. D., J. J. Coalson, J. Peters, A. Chaparro, C. Techasaensiri, A. M. Cantwell, T. R. Kannan, J. B. Baseman, and P. H. Dube. 2009. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. [Published erratum appears in 2009 PLoS One 4: 10.1371/annotation/616385db-f413-4f23-ba78-2fe626870e46.] PLoS One 4: e7562. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007562.
36. Kannan, T. R., O. Musatovova, S. Balasubramanian, M. Cagle, J. L. Jordan, T. M. Krunkosky, A. Davis, R. D. Hardy, and J. B. Baseman. 2010. Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation. Mol. Microbiol. 76: 1127-1141.
37. Voynow, J. A., L. R. Young, Y. Wang, T. Horger, M. C. Rose, and B. M. Fischer. 1999. Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells. Am. J. Physiol. 276: L835-L843.
38. Kraft, M., K. B. Adler, J. L. Ingram, A. L. Crews, T. P. Atkinson, C. B. Cairns, D. C. Krause, and H. W. Chu. 2008. Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma. Eur. Respir. J. 31: 43-46.
39. Shimizu, T., Y. Kida, and K. Kuwano. 2008. Mycoplasma pneumoniae-derived lipopeptides induce acute inflammatory responses in the lungs of mice. Infect. Immun. 76: 270-277.
40. Hao, Y., Z. Kuang, J. Jing, J. Miao, L. Y. Mei, R. J. Lee, S. Kim, S. Choe, D. C. Krause, and G. W. Lau. 2014. Mycoplasma pneumoniae modulates STAT3-STAT6/EGFR-FOXA2 signaling to induce overexpression of airway mucins. Infect. Immun. 82: 5246-5255.
41. Hasegawa, Y., M. Takahashi, S. Ariki, D. Asakawa, M. Tajiri, Y. Wada, Y. Yamaguchi, C. Nishitani, R. Takamiya, A. Saito, et al. 2015. Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling. Oncogene 34: 838-845.